# ViGenCell

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vigencell

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.vigencell.com
- Total disclosed funding: $25M
- Latest round: Series B (Apr 9, 2019)
- Investors on record: 8

## About

Based in Seoul, South Korea, ViGenCell Inc. is a biotechnology company specializing in immune cell therapy. The firm was founded as the first subsidiary of Catholic University Technology Holdings Co., Ltd. in 2013. In December 2024, GAEUN GLOBAL Co.,Ltd acquired an 11.37% minority stake in ViGenCell from Boryung Biopharma Co., Ltd. The firm as of December 2024, is led by its CEO, Kim Tae-gyu.

The company focuses on the development of advanced immunotherapies utilizing T cells, myeloid-derived suppressor cells (MDSC), and gamma-delta T cells, aimed at improving patient outcomes and extending lives with intractable diseases. Bizencell’s core technologies include its ViTier™ antigen-specific killer T cell therapy, ViMedier™ cord blood-derived myeloid suppressor cell therapy, and ViRanger™ universal T cell gene therapy. These therapies are designed to target specific cancer cells or modulate immune responses in conditions like leukemia, lymphoma, atopic dermatitis, and graft-versus-host disease.

## Funding rounds

- Series B, Apr 9, 2019, $18M — Hana Bank, Shinhan Venture Investment, Premier Partners, Albatross Investment, DAYLI Partners, Tigris Investment
- Series A, Dec 22, 2017, $7.4M — Woori Bank, Shinhan Venture Investment, Brain Asset Management, Premier Partners, Albatross Investment

## Investors

- Woori Bank — Series A
- Shinhan Venture Investment (https://capitalatlas.ai/funds/shinhan-venture-investment) — Series A, Series B
- Brain Asset Management (https://capitalatlas.ai/funds/brain-asset-management) — Series A
- Premier Partners (https://capitalatlas.ai/funds/premier-partners) — Series A, Series B
- Albatross Investment (https://capitalatlas.ai/funds/albatross-investment) — Series A, Series B
- Hana Bank — Series B
- DAYLI Partners (https://capitalatlas.ai/funds/dayli-partners) — Series B
- Tigris Investment (https://capitalatlas.ai/funds/tigris-investment) — Series B